UY25460A1 - Procedimiento para la preparacion de acidos hidroxamicos. - Google Patents

Procedimiento para la preparacion de acidos hidroxamicos.

Info

Publication number
UY25460A1
UY25460A1 UY25460A UY25460A UY25460A1 UY 25460 A1 UY25460 A1 UY 25460A1 UY 25460 A UY25460 A UY 25460A UY 25460 A UY25460 A UY 25460A UY 25460 A1 UY25460 A1 UY 25460A1
Authority
UY
Uruguay
Prior art keywords
preparation
procedure
hydroxamic acids
hydroxy
alkyl
Prior art date
Application number
UY25460A
Other languages
English (en)
Spanish (es)
Inventor
Michael Hawkins Joel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY25460A1 publication Critical patent/UY25460A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
UY25460A 1998-04-10 1999-04-07 Procedimiento para la preparacion de acidos hidroxamicos. UY25460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
UY25460A1 true UY25460A1 (es) 1999-11-17

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25460A UY25460A1 (es) 1998-04-10 1999-04-07 Procedimiento para la preparacion de acidos hidroxamicos.

Country Status (38)

Country Link
US (1) US6288246B1 (enExample)
EP (1) EP0949244A3 (enExample)
JP (1) JPH11343277A (enExample)
KR (1) KR100329902B1 (enExample)
CN (1) CN1232023A (enExample)
AP (1) AP1203A (enExample)
AR (1) AR018180A1 (enExample)
AU (1) AU747629B2 (enExample)
BG (1) BG64154B1 (enExample)
BR (1) BR9901089A (enExample)
CA (1) CA2268680A1 (enExample)
CO (1) CO5070713A1 (enExample)
DZ (1) DZ2757A1 (enExample)
EA (1) EA002777B1 (enExample)
EG (1) EG22263A (enExample)
GT (1) GT199900046A (enExample)
HR (1) HRP990105A2 (enExample)
HU (1) HUP9901041A3 (enExample)
ID (1) ID23337A (enExample)
IL (1) IL129328A0 (enExample)
IN (1) IN192342B (enExample)
IS (1) IS5019A (enExample)
MA (1) MA24831A1 (enExample)
NO (1) NO991672L (enExample)
NZ (1) NZ335104A (enExample)
OA (1) OA11031A (enExample)
PA (1) PA8469301A1 (enExample)
PE (1) PE20000418A1 (enExample)
PL (1) PL332450A1 (enExample)
SG (1) SG125880A1 (enExample)
SK (1) SK43699A3 (enExample)
TN (1) TNSN99052A1 (enExample)
TR (1) TR199900755A3 (enExample)
TW (1) TW448147B (enExample)
UA (1) UA57750C2 (enExample)
UY (1) UY25460A1 (enExample)
YU (1) YU18199A (enExample)
ZA (1) ZA992631B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
WO2005023757A1 (ja) * 2003-08-29 2005-03-17 Basf Aktiengesellschaft ヒドロキシルアミン0−置換体の製造方法
AU2014366937B2 (en) 2013-12-18 2019-03-21 Brita Lp Container for filter-as-you-pour system
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Alk﹘5抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
EP0922030A1 (en) 1996-08-23 1999-06-16 Pfizer Inc. Arylsulfonylamino hydroxamic acid derivatives
HUP0000852A2 (hu) 1997-02-03 2001-05-28 Pfizer Products Inc. Aril-szulfonil-amino-hidroxámsav-származékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
TR200000368T2 (tr) 1997-08-08 2000-07-21 Pfizer Products Inc. Ariloksiariarilsülfonilamino hidroksamik asit türevleri.
DE69805473T2 (de) 1997-08-08 2003-01-16 Pfizer Products Inc., Groton Arylsulfonylaminohydroxamsäurederivate
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
ZA992631B (en) 2000-10-09
HUP9901041A3 (en) 2003-02-28
CN1232023A (zh) 1999-10-20
AP9901503A0 (en) 1999-06-30
PE20000418A1 (es) 2000-05-23
HUP9901041A2 (hu) 2000-03-28
EA199900284A2 (ru) 1999-10-28
UA57750C2 (uk) 2003-07-15
IN192342B (enExample) 2004-04-10
EA002777B1 (ru) 2002-08-29
SG125880A1 (en) 2006-10-30
EG22263A (en) 2002-11-30
EA199900284A3 (ru) 2000-04-24
CA2268680A1 (en) 1999-10-10
AU2369099A (en) 1999-10-21
JPH11343277A (ja) 1999-12-14
KR19990083051A (ko) 1999-11-25
HU9901041D0 (en) 1999-06-28
GT199900046A (es) 2000-09-15
TW448147B (en) 2001-08-01
US6288246B1 (en) 2001-09-11
CO5070713A1 (es) 2001-08-28
BG103319A (en) 2001-08-31
EP0949244A3 (en) 2001-05-30
NO991672L (no) 1999-10-11
AR018180A1 (es) 2001-10-31
NZ335104A (en) 2000-10-27
OA11031A (en) 2002-02-07
BG64154B1 (bg) 2004-02-27
SK43699A3 (en) 2000-06-12
NO991672D0 (no) 1999-04-09
ID23337A (id) 2000-04-05
KR100329902B1 (ko) 2002-03-22
TR199900755A2 (xx) 1999-11-22
IL129328A0 (en) 2000-02-17
PL332450A1 (en) 1999-10-11
PA8469301A1 (es) 2000-09-29
MA24831A1 (fr) 1999-12-31
AU747629B2 (en) 2002-05-16
BR9901089A (pt) 2000-05-30
EP0949244A2 (en) 1999-10-13
DZ2757A1 (fr) 2003-09-15
TR199900755A3 (tr) 1999-11-22
TNSN99052A1 (fr) 2005-11-10
AP1203A (en) 2003-09-05
YU18199A (sh) 2002-11-15
HRP990105A2 (en) 2000-02-29
IS5019A (is) 1999-10-11

Similar Documents

Publication Publication Date Title
ES2622004T3 (es) Derivado de diazabiciclooctano ópticamente activo y método para preparar el mismo
ATE246672T1 (de) Oligomere diarylbutadiene
PT84060B (pt) Processo para a preparacao de acidos 2-arilpropionicos
DE69706366D1 (de) Verfahren zur Herstellung von Paroxetine
DE60016629T2 (de) Ox(adi)azoly-hydroxamsäuren und ihre verwendung als prokollagen c-proteinase inhibitoren
ATE113660T1 (de) Phenylglycidat-stereoisomere, umsetzungsprodukte mit 2-nitrothiophenol und herstellung von diltiazen.
ATE71086T1 (de) Verfahren zur herstellung von optischen aktiven 3-(methan-sulfonyloxy)thioland und analoge.
ATE551312T1 (de) Verfahren zur racematspaltung von zopiclon und zwischenprodukten
JPH10259175A (ja) N−アシル−ヒドロキシアミノ酸エステル及びそれらの使用
IT1244699B (it) Processo per la preparazione di acidi 3 acilammino-4- carbamoilossimetil-2-azetidinone-l-solfonici ed intermedi per la loro preparazione
PT84620B (pt) Processo para a preparacao de novos compostos relacionados com a espergualina
ITMI20021861A1 (it) Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
FI69051B (fi) Foerfarande foer omvandling av konfigurationen i optiskt aktiva foereningar och haertill erforderliga nya optiskt aktiva mellanprodukter och deras salter
BR9712144A (pt) Novos antagonistas de nmda (d- aspartato de n-metila).
Park et al. Synthesis of optically active 2-alkyl-3, 4-iminobutanoic acids. β-Amino acids containing an aziridine heterocycle
AR035076A1 (es) Procedimiento y derivados ester utiles para la preparacion de cefalosporinas
AR050100A1 (es) Procedimiento para preparar las formas enantiomeras de derivados de acido 3 hidroxiciclohexanocarboxilico con configuracion cis
MXPA03001314A (es) Proceso para la preparacion de alfa'-clorocetonas.
CA2001515A1 (en) Process for preparing optically active glycidate esters
ATE207921T1 (de) Verfahren zur herstellung von tetrahydroindolizinen
IE882938L (en) Phosphinic acid derivatives
DE50111010D1 (de) Topische zusammensetzung, enthaltend mindestens ein aryloxim, und verfahren zu ihrer herstellung
AU2014324650A1 (en) Compounds and methods for skin repair
TR199900755A2 (xx) Hidroksamik asitlerin haz�rlanmas�na y�nelik proses
ATE296793T1 (de) Verfahren zur herstellung von aliphatischen, zykloaliphatischen oder araliphatischen chlorameisensäureestern

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20110523